MOLLOY ANTHONY 4
4 · Pacira BioSciences, Inc. · Filed Jan 6, 2023
Insider Transaction Report
Form 4
MOLLOY ANTHONY
Chief Lgl & Compliance Officer
Transactions
- Sale
Common Stock
2023-01-04$39.09/sh−158$6,177→ 19,996 total - Sale
Common Stock
2023-01-05$38.31/sh−546$20,917→ 19,450 total
Footnotes (3)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]Includes 204 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.